US Patent Issued to The University of Hong Kong on June 2 for "MRGPRX2 antagonist for the treatment of pseudo allergic reactions" (Chinese Inventors)

ALEXANDRIA, Va., June 2 -- United States Patent no. 12,642,795, issued on June 2, was assigned to The University of Hong Kong (Hong Kong).

"MRGPRX2 antagonist for the treatment of pseudo allergic reactions" was invented by Mukesh Kumar (Hong Kong), Kailash Singh (Hong Kong) and Billy Kwok Chong Chow (Hong Kong).

According to the abstract* released by the U.S. Patent & Trademark Office: "Compounds that have antiallergic and/or anti-inflammatory properties and methods of making thereof are disclosed. These compounds can block MMRGPRX2 and prevent or reduce mast cells activation. Pharmaceutical formulations in a unit dosage form suitable for the delivery of the compounds to a subject in need thereof are disclosed. The pharmaceutical formulat...